Literature DB >> 7372384

The diffusion of the computed tomography (CT) scanner in the United States.

H D Banta.   

Abstract

The rising cost of medical care in the United States is a problem generally familiar to all interested in health care policy. In recent years the contribution of technology to this rising cost has been debated. The computed tomography (CT) scanner has come to exemplify the problem of "technology run wild." The scanner was introduced into the United States in 1973 and has diffused rapidly into virtually every area of the country. However, despite the large number of scanners, they are mal-distributed by institutional setting and geographic location. A number of Federal policies have been developed to deal with medical technology. The case of the CT scanner illustrates the failure of these policies. The CT scanner was not well evaluated before it diffused into practice, and it appears that Federal reimbursement policy facilitated its spread. Federal policies designed to slow diffusion or to assure optimal placement or wise use of scanners have not had demonstrable effects. The case of the CT scanner suggests the need to alter Federal policies toward medical technologies.

Mesh:

Year:  1980        PMID: 7372384     DOI: 10.2190/6D17-3UAU-RAM1-NVTR

Source DB:  PubMed          Journal:  Int J Health Serv        ISSN: 0020-7314            Impact factor:   1.663


  3 in total

1.  A comparison of in-house and regionalized computerized tomography scanning: clinical impact and cost.

Authors:  A Elixhauser; D M Reker; K N Gillespie; J Fletcher; F D Wolinsky
Journal:  Health Serv Res       Date:  1990-04       Impact factor: 3.402

2.  The Effect of Physician and Hospital Market Structure on Medical Technology Diffusion.

Authors:  Pinar Karaca-Mandic; Robert J Town; Andrew Wilcock
Journal:  Health Serv Res       Date:  2016-05-16       Impact factor: 3.402

3.  Government health policy and the diffusion of new medical devices.

Authors:  B J Hillman
Journal:  Health Serv Res       Date:  1986-12       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.